Literature DB >> 8014297

Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosing.

G Brown, J P McCormack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8014297     DOI： 10.1007/bf01704712

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  8 in total

Review 1.  A critical reevaluation of the "therapeutic range" of aminoglycosides.

Authors:  J P McCormack; P J Jewesson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections.

Authors:  H Mattie
Journal:  Clin Investig       Date:  1993-06

3.  Initial aminoglycoside levels in the critically ill.

Authors:  W R Summer; J R Michael; J J Lipsky
Journal:  Crit Care Med       Date:  1983-12       Impact factor: 7.598

4.  Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.

Authors:  F Konrad; R Wagner; B Neumeister; H Rommel; M Georgieff
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.

Authors:  C P Andrews; J J Coalson; J D Smith; W G Johanson
Journal:  Chest       Date:  1981-09       Impact factor: 9.410

6.  Aminoglycoside ototoxicity in the human.

Authors:  W E Fee
Journal:  Laryngoscope       Date:  1980-10       Impact factor: 3.325

7.  Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration.

Authors:  A R Beaubien; E Ormsby; A Bayne; K Carrier; G Crossfield; M Downes; R Henri; M Hodgen
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.

Authors:  D E Craven; L M Kunches; V Kilinsky; D A Lichtenberg; B J Make; W R McCabe
Journal:  Am Rev Respir Dis       Date:  1986-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.